Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: Impulsivity as main target

Journal of Clinical Psychiatry

Volumn 66, Issue 10, 2005, Pages 1298-1303

  Villeneuve, Evens ^a   Lemelin, Sophie ^a,b  

^a CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^b Clinique Le Faubourg St Jean   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; QUETIAPINE;

ADULT; ANXIETY; ARTICLE; BORDERLINE STATE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GASTROINTESTINAL SYMPTOM; HAMILTON SCALE; HOSTILITY; HUMAN; IMPULSIVENESS; MALE; MOOD DISORDER; PARKINSONISM; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; RATING SCALE; SIDE EFFECT; SOCIAL ADAPTATION; SOCIAL BEHAVIOR; TREATMENT OUTCOME; TREMOR; WEIGHT GAIN;

EID: 27544468326     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v66n1013     Document Type: Article

References (25)

1. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Borderline Personality Disorder. Am J Psychiatry 2001;158(suppl 10):1-52
2. Soloff PH. Psychopharmacology of borderline personality disorder. Psychiatr Clin North Am 2000;23:169-192
3. Links PS, Heslegrave R, van Reekum R. Impulsivity: core aspect of borderline personality disorder. J Personal Disord 1999;13:1-9
4. Zanarini MC. Update on pharmacotherapy of borderline personality disorder. Curr Psychiatry Rep 2004;6:66-70
5. Adityanjee, Schulz SC. Clinical use of quetiapine in disease states other than schizophrenia. J Clin Psychiatry 2002;63(suppl 13):32-38
6. Hilger E, Barnas C, Kasper S. Quetiapine in the treatment of borderline personality disorder. World J Biol Psychiatry 2003;4:42-44
7. Gunderson JG, Kolb JE, Austin V. The diagnostic interview for borderline patients. Am J Psychiatry 1981;138:896-903
8. Zanarini MC, Gunderson JG, Frankenburg FR. The revised Diagnostic Interview for Borderlines: discriminating BPD from other Axis II disorders. J Personal Disord 1989;3:10-18
9. Global Assessment of Functioning. In: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987:12
10. Lingjaerde O, Ahlfors UG, Bech P, et al. The UKU Side Effect Rating Scale. Acta Psychiatr Scand 1987;76(suppl 334):1-100
11. Chouinard G, Ross-Chouinard A, Annable L, et al. The Extrapyramidal Symptom Rating Scale [abstract]. Can J Neurol Sci 1980;7:233
12. Barratt ES. Anxiety and impulsiveness related to psychomotor efficiency. Percept Mot Skills 1959;9:191-198
13. Baylé FJ, Bourdel M, Caci H, et al. Structure factorielle de la traduction française de l'échelle d'impulsivité de Barratt (BIS-10). [Factor analysis of French translation of the Barratt Impulsivity Scale (BIS-10).] Can J Psychiatry 2000;45:156-165
14. Buss AH, Durkee A. An inventory for assessing different kinds of hostility. J Consult Psychol 1957;21:343-349
15. Beck AT, Weissman A, Lester D, et al. The measurement of pessimism: the Hopelessness Scale. J Consult Clin Psychol 1974;42:861-865
16. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
17. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-55
18. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812
19. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993;50:975-990
20. Weissman MJM, Paykel ES. The Depressed Woman: a Study of Social Relationships. Chicago, Ill: University of Chicago Press; 1974
21. Weissman MM. Social Adjustment Scale-Self-Reported. User's Manual. New York, NY: Multi-Health Systems Inc; 1999
22. Dickman SJ. Functional and dysfunctional impulsivity: personality and cognitive correlates. J Pers Soc Psychol 1990;58:95-102
23. Svrakic DM, Whitehead C, Przybeck TR, et al. Differential diagnosis of personality disorders by the seven-factor model of temperament and character. Arch Gen Psychiatry 1993;50:991-999
24. Soloff PH, Cornelius J, George A, et al. Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 1993;50:377-385
25. Rinne T, van den Brink W, Wouters L, et al. SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry 2002;159:2048-2054